RenovoRx Historical Income Statement

RNXT Stock

USD 1.21 0.02 1.68%

Historical analysis of RenovoRx income statement accounts such as Selling General Administrative of 3.5 M, Total Revenue of 0.0, Other Operating Expenses of 7.5 M or Research Development of 4 M can show how well RenovoRx performed in making a profits. Evaluating RenovoRx income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of RenovoRx's future profits or losses.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining RenovoRx latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether RenovoRx is a good buy for the upcoming year.

Net Income Gross Profit

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in RenovoRx. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.

For more information on how to buy RenovoRx Stock please use our How to Invest in RenovoRx guide.

About RenovoRx Income Statement Analysis

RenovoRx Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to RenovoRx shareholders. The income statement also shows RenovoRx investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

RenovoRx Income Statement Chart

At this time, RenovoRx's Net Interest Income is comparatively stable compared to the past year. Total Other Income Expense Net is likely to gain to about 1.2 M in 2024, whereas Interest Income is likely to drop slightly above 64.3 K in 2024.

Selling General Administrative Other Operating Expenses Research Development Total Operating Expenses

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of RenovoRx. It is also known as RenovoRx overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Total Operating Expenses

The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.

Most accounts from RenovoRx's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into RenovoRx current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in RenovoRx. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.

For more information on how to buy RenovoRx Stock please use our How to Invest in RenovoRx guide.At this time, RenovoRx's Net Interest Income is comparatively stable compared to the past year. Total Other Income Expense Net is likely to gain to about 1.2 M in 2024, whereas Interest Income is likely to drop slightly above 64.3 K in 2024.

	2021	2023	2024 (projected)
Depreciation And Amortization	9K	5.4K	5.1K
Interest Income	57K	111K	64.4K

Depreciation And Amortization Interest Income

RenovoRx income statement Correlations

	Net Interest Income	Interest Income	Depreciation And Amortization	Selling General Administrative	Other Operating Expenses	Operating Income	Net Income From Continuing Ops	Ebit	Research Development	Ebitda	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Gross Profit	Cost Of Revenue	Selling And Marketing Expenses
Net Interest Income		0.55	-0.54	0.03	0.12	-0.15	-0.02	0.0	0.31	-0.14	0.12	-0.05	0.65	0.04	-0.99	0.22	-0.24	-0.2
Interest Income	0.55		-0.79	0.44	0.54	-0.48	-0.36	-0.25	0.71	-0.48	0.54	-0.39	0.69	-0.34	-0.5	0.34	-0.45	-0.34
Depreciation And Amortization	-0.54	-0.79		-0.19	-0.24	0.24	0.19	-0.04	-0.34	0.23	-0.24	0.19	-0.41	0.13	0.56	-0.16	0.16	0.12
Selling General Administrative	0.03	0.44	-0.19		0.99	-0.95	-0.96	-0.89	0.91	-0.95	0.99	-0.94	0.52	-0.94	0.03	0.94	-0.94	-0.52
Other Operating Expenses	0.12	0.54	-0.24	0.99		-0.96	-0.94	-0.89	0.96	-0.96	1.0	-0.94	0.61	-0.92	-0.05	0.93	-0.95	-0.56
Operating Income	-0.15	-0.48	0.24	-0.95	-0.96		0.98	0.96	-0.92	1.0	-0.96	0.99	-0.72	0.98	0.06	-0.93	0.98	0.76
Net Income From Continuing Ops	-0.02	-0.36	0.19	-0.96	-0.94	0.98		0.95	-0.84	0.98	-0.94	1.0	-0.59	0.99	-0.04	-0.94	0.95	0.7
Ebit	0.0	-0.25	-0.04	-0.89	-0.89	0.96	0.95		-0.82	0.96	-0.89	0.97	-0.64	0.97	-0.1	-0.89	0.96	0.79
Research Development	0.31	0.71	-0.34	0.91	0.96	-0.92	-0.84	-0.82		-0.92	0.96	-0.86	0.77	-0.84	-0.22	0.85	-0.93	-0.62
Ebitda	-0.14	-0.48	0.23	-0.95	-0.96	1.0	0.98	0.96	-0.92		-0.96	0.99	-0.72	0.98	0.05	-0.93	0.98	0.76
Total Operating Expenses	0.12	0.54	-0.24	0.99	1.0	-0.96	-0.94	-0.89	0.96	-0.96		-0.94	0.61	-0.92	-0.05	0.93	-0.95	-0.56
Income Before Tax	-0.05	-0.39	0.19	-0.94	-0.94	0.99	1.0	0.97	-0.86	0.99	-0.94		-0.65	1.0	-0.03	-0.92	0.96	0.76
Total Other Income Expense Net	0.65	0.69	-0.41	0.52	0.61	-0.72	-0.59	-0.64	0.77	-0.72	0.61	-0.65		-0.59	-0.53	0.58	-0.75	-0.83
Net Income	0.04	-0.34	0.13	-0.94	-0.92	0.98	0.99	0.97	-0.84	0.98	-0.92	1.0	-0.59		-0.13	-0.9	0.94	0.74
Income Tax Expense	-0.99	-0.5	0.56	0.03	-0.05	0.06	-0.04	-0.1	-0.22	0.05	-0.05	-0.03	-0.53	-0.13		-0.18	0.15	0.06
Gross Profit	0.22	0.34	-0.16	0.94	0.93	-0.93	-0.94	-0.89	0.85	-0.93	0.93	-0.92	0.58	-0.9	-0.18		-0.96	-0.55
Cost Of Revenue	-0.24	-0.45	0.16	-0.94	-0.95	0.98	0.95	0.96	-0.93	0.98	-0.95	0.96	-0.75	0.94	0.15	-0.96		0.73
Selling And Marketing Expenses	-0.2	-0.34	0.12	-0.52	-0.56	0.76	0.7	0.79	-0.62	0.76	-0.56	0.76	-0.83	0.74	0.06	-0.55	0.73

Click cells to compare fundamentals

RenovoRx Account Relationship Matchups

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for RenovoRx Stock Analysis

When running RenovoRx's price analysis, check to measure RenovoRx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy RenovoRx is operating at the current time. Most of RenovoRx's value examination focuses on studying past and present price action to predict the probability of RenovoRx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move RenovoRx's price. Additionally, you may evaluate how the addition of RenovoRx to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

RenovoRx Historical Income Statement

About RenovoRx Income Statement Analysis

RenovoRx Income Statement Chart

Other Operating Expenses

Total Operating Expenses

RenovoRx income statement Correlations

RenovoRx Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for RenovoRx Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Operating Expenses	+ 1.0	Other Operating Expenses
Ebitda	+ 1.0	Operating Income
Income Before Tax	+ 1.0	Net Income From Continuing Ops
Net Income	+ 1.0	Income Before Tax
Other Operating Expenses	+ 0.99	Selling General Administrative
Total Operating Expenses	+ 0.99	Selling General Administrative

Income Tax Expense	- 0.99	Net Interest Income
Cost Of Revenue	- 0.96	Gross Profit
Total Operating Expenses	- 0.96	Ebitda
Total Operating Expenses	- 0.96	Operating Income
Ebitda	- 0.96	Other Operating Expenses
Operating Income	- 0.96	Other Operating Expenses